NCT00238472View on ClinicalTrials.gov

A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

nateglinide

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY